NCT06784024View on ClinicalTrials.gov

Topical Lidocaine vs. Traditional Management in Manual Vacuum Aspiration Pain Management.

NACompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

January 15, 2025

Primary Completion Date

July 1, 2025

Study Completion Date

August 20, 2025

Conditions
Endometrial HyperplasiaEndometrial Diseases
Interventions
DRUG

Lidocaine topical

Topical lidocaine (SPRAY SOLUTION 10 g) 10% will be applied to the cervix and cervical canal prior to the MVA procedure in a number of 20 sprays separated by 3 seconds between each spray (0.06 ml/spray).

OTHER

Saline solution

Placebo (0.9% saline) will be applied topically to the cervix and cervical canal prior to the MVA procedure in a number of 20 sprays separated by 3 seconds between each spray (0.06 ml / spray).

Trial Locations (1)

11101

Hospital Escuela, Tegucigalpa

All Listed Sponsors
lead

Ricardo A Gutierrez Ramirez, MD, MSc, FACOG

OTHER

NCT06784024 - Topical Lidocaine vs. Traditional Management in Manual Vacuum Aspiration Pain Management. | Biotech Hunter | Biotech Hunter